The burgeoning AI space is bristling with potential for application in clinical trials, from study startup and recruitment to site monitoring visits, protocol simplification and greater operational efficiency overall. But widespread adoption will first require industry to properly evaluate and show the value of solutions in this still-evolving area. The CenterWatch Monthly reached out to several experts to gather insights on how AI is being used and what value it has for clinical trials.Read More
Making clinical trials truly representative of the disease populations they target is not an effort confined solely to the U.S. and FDA; it is a global initiative with many considerations that differ by country, culture and regulatory agency. The CenterWatch Monthly interviewed Liz Beatty, cofounder and chief strategy officer at Inato, a tech provider focused on boosting trial inclusivity and access around the world, to discuss thinking from an international perspective on diversity, equity and inclusion (DE&I).Read More
This month’s guest columnist, Susan Landis, executive director of the Association of Clinical Research Professionals (ACRP), explains why the clinical research workforce is in crisis and how ACRP is on a mission to fix it.Read More
WCG’s recent virtual conference, MAGI@home, featured expert commentary on a number of important clinical research topics, including clinical operations, quality and regulatory issues, budgets ad contracts, and billing compliance. The following are some insights from conference presenters.
Recruitment has long been known to be one of the most difficult parts of clinical research and can be the biggest hurdle for sites just getting into trials. In this new CenterWatch Monthly column on sites’ startup successes, Ruby Hussain, owner and principal investigator of Prime Global Research, a site based in The Bronx, N.Y., recalls how her site overcame major recruitment challenges they encountered despite being in one of the most densely populated areas of the U.S.Read More